LONG-TERM RESULTS OF INTERFERON TREATMENT IN HAIRY-CELL LEUKEMIA

被引：12

作者：

CAPNIST, G

FEDERICO, M

CHISESI, T

RESEGOTTI, L

LAMPARELLI, T

FABRIS, P

ROSSI, G

INVERNIZZI, R

GUARNACCIA, C

LEONI, P

LAURIA, F

PAGNUCCO, G

FRASSOLDATI, A

DAMASIO, E

机构：

[1] San Bortolo Hospital, Vicenza University of Modena

[2] Molinette Hospital, Torino

[3] San Martino Hospital, Genova

[4] Regional Hospital, Bolzano

[5] Regional Hospital, Brescia

[6] Cervello Hospital, Palermo

[7] Sant'Orsola Hospital, Bologna

[8] San Matteo Hospital, Pavia

来源：

LEUKEMIA & LYMPHOMA | 1994年 / 14卷 / 5-6期

关键词：

HAIRY CELL LEUKEMIA; INTERFERON;

D O I：

10.3109/10428199409049704

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Eighty nine of 104 patients with hairy cell leukemia (HCL), enrolled between 1985 and 1987 in a multicenter prospective study on human lymphoblastoid IFN alpha-n1, were evaluable for long-term follow-up. The induction treatment, 3 MU/mq daily for a median of 5.7 months, produced a response of 93%, complete + partial response (CR + PR) = 80%, minor (MR) = 13%. Neither prior splenectomy nor pre-treatment variables were associated with the rate of response to IFN. However maintenance treatment of 3 MU/mq weekly given randomly had a highly significant effect on failure free survival (FFS). Of the 43 patients who relapsed, 31/36 (86%) obtained a new response with IFN. No differences in FFS were recorded between first and second response. At the third induction 7/11 patients were treated again with IFN, 4/7 obtaining some response, but the FFS was significantly worse. The overall survival is still 85%. We conclude that (1) IFN should be used as chronic uninterrupted treatment for HCL, (2) reduced dosage is sufficient to prolong the disease free status and (3) continuous lymphoblastoid IFN administration seems not to be associated with the development of resistance to retreatment.

引用

页码：457 / 464

页数：8

共 37 条

[1]

Quesada J.R., Reuben J.R., Manning J.T., Hersh E.M., Gutterman J.U., Alpha interferon for induction of remission in hairy cell leukemia, N. Engl. J. Med., 310, pp. 15-18, (1984)

[2]

Worman C.P., Catovsky D., Bevan P.C., Camba L., Joyner M., Green P.J., William H.J.H., Bottomley J.M., Gordon-Smith E.C., Cawley J.C., Interferon is effective in hairy cell leukemia, Br. J. Haematol., 60, pp. 759-763, (1985)

[3]

Ratain M.J., Golomb H.M., Vardiman J.W., Vokes E.E., Jacobs R.H., Daly K., Treatment of hairy cell leukemia with recombinant alpha interferon, Blood, 65, pp. 644-648, (1985)

[4]

Huber C., Flener R., Gastl G., Interferon-alpha-2c in the treatment of advanced hairy cell leukemia, Oncology, 42, pp. 7-9, (1985)

[5]

Jacobs A.D., Naiem F., Champlin R.E., Golde D.W., Toxicity and bone marrow response of patients with hairy cell leukemia treated with biosyntetic (recombinant) alfa2-interferon, Blul, 50, pp. 33-34, (1985)

[6]

Thompson J.A., Brady J., Kidd P., Fefer A., Recombinant alpha-2 interferon in the treatment of hairy cell leukemia, Cancer Treat. Rep., 69, pp. 791-793, (1985)

[7]

Foon K., Maluish A., Abrams P., Wrightington S., Stevenson H., Alarif A., Fer M., Overton W., Poole M., Schnipper E., Jaffe E., Herberman R., Recombinant leukocyte A interferon therapy for advanced hairy cell leukemia, Am. J. Med., 80, pp. 351-356, (1986)

[8]

Quesada J.R., Hersh E.M., Manning J., Reuben J., Keating M., Schnipper E., Itri L., Gutterman J.U., Treatment of hairy cell leukemia with recombinant alpha-interferon, Blood, 68, pp. 493-497, (1986)

[9]

Golomb H.M., Jacobs A., Fefer A., Ozer H., Thompson J., Portlock C., Ratain M., Golde D., Vardiman J., Burke J., Brady J., Bonnem E., Spiegel R., Alpha-2-interferon therapy of hairy cell leukemia: A multicenter study of 64 patients, J. Clin. Oncol., 4, pp. 900-905, (1986)

[10]

Ehmann W.C., Silbert R., Recombinant alpha-2 interferon for treatment of hairy cell leukemia without prior splenectomy, Am. J. Med., 80, pp. 1111-1114, (1986)

← 1 2 3 4 →